JP Morgan Chase
BIOR

JP Morgan Chase’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

JP Morgan Chase’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31
Closed -$5K – 7084
2022
Q2 		$5K Sell
31
-106
-77% -$22.3K ﹤0.01% 6185
2022
Q1 		$40K Buy
+137
New +$52K ﹤0.01% 5879

JP Morgan Chase's BIOR Position: Q4 2024 in Review

JP Morgan Chase sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 2 shares — an estimated $11 sold.

JP Morgan Chase first reported a position in BIOR in Q3 2020 and held it in 9 quarters. The position peaked at $230K in Q1 2021. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.

  • JP Morgan Chase reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • JP Morgan Chase sold 2 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $11.
  • JP Morgan Chase first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • JP Morgan Chase's Biora Therapeutics, Inc. Common Stock position peaked at $230K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.